chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-02-10 AccNo: 0001387131-16-004120 Size: 99 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-02-09 AccNo: 0001387131-16-004111 Size: 1 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2016-02-09 16:30 After Market Close:OHR PHARMACEUT Earning Release . Wall St EPS Est ($):-0.24. 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-02-01 AccNo: 0001387131-16-004033 Size: 69 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-01-29 AccNo: 0001387131-16-003992 Size: 85 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ DEF 14A - Other definitive proxy statements Filed: 2016-01-29 AccNo: 0001387131-16-004018 Size: 1 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2015-12-14 AccNo: 0001387131-15-003603 Size: 4 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2015-12-10 AccNo: 0001387131-15-003593 Size: 99 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2015-12-10 16:30 After Market Close:OHR PHARMACEUT Earning Release . Wall St EPS Est ($):-0.24. 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2015-12-10 16:30 After Market Close:OHR PHARMACEUT Earning Release . Wall St EPS Est ($):-0.24. 网页链接